Clinical Trial Update: Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders

View source ↗

Summary

This clinical trial update discusses how molecular markers influence clinical management and therapy in myeloproliferative neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myeloproliferative Neoplasms | Status: UNKNOWN